Search results
An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the body).
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Celebrate the life of your loved one, by donating in their memory and help us fund more research and support, now.
These are some of the most commonly asked questions about volunteering for our charity.
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
The Great North Run is the largest half marathon in the world, taking place annually in North East England.
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
My name is Mark Baxter and from an early age I was diagnosed with a deteriorating retinal eye condition called retinitis pigmentosa or RP for short, which will slowly lead to blindness.
